PharmaDiscovery 2005 Exhibitor Profiles.

WASHINGTON -- PharmaDiscovery 2005 takes place May 11 - 12 at the Washington, D.C. Convention Center. For in-depth information about the event visit http://www.pharmadiscovery2005.com.

Below are profiles from PharmaDiscovery 2005 exhibitors; breaking news releases are available at http://www.tradeshownews.com, Business Wire's trade show, conference and event news resource. Business Wire is the official news wire service for PharmaDiscovery 2005.

Company: Asterand, Inc.
Booth/Stand: 504
Media Contact: Apurvi Desai
Phone:    [phone]
E-mail:   [e-mail]
Web: www.asterand.com

Product description: Asterand offers a wide range of human
tissue-based research services. This includes:

Frozen & Fixed tissues
Fresh tissues
Blood, Serum, Plasma
Synovial fluid
Cerebrospinal fluid (CSF)
Tissue Microarrays (TMAs)
RNA, DNA & protein
DNA isolation
RNA isolation
Immunohistochemistry (IHC)
In situ hybridization (ISH)

Company description: Asterand offers human tissue-based services
to fit a broad range of interests including both small academic and
large commercial research studies. Our worldwide network of donor
sites has enabled collection of over 200,000 human tissue samples
reflecting every area of pharmacologic interest. Each sample is
accompanied by extensive donor clinical and pathology information and
is backed by rigorous quality control standards.

Company: Cellectricon
Booth/Stand: 202
Media Contact: Susanne Orwar
Phone:    [phone]
E-mail:   [e-mail]
Web: http://www.cellectricon.com/

Product description: Dynaflow(TM) is a new system for ion channel
drug discovery and is already used by 8 of the 10 largest
pharmaceutical companies in the world. The system integrates
chip-based microfluidics with conventional patch clamp for superior
data quality, throughput, and ease of operation. Dynaflow(TM) offers
major savings in time and cost and reduces the amount of reagents by a
factor of ~100.

Company description: Cellectricon is a biotechnology company
active in the pioneering interface of microtechnology and biology and
invents new types of functional cell-based assays and devices.
Currently the company is focusing on two areas, ion channels analysis
and intracellular screening applications (RNAi and intracellular
targets). The Company's products cover early steps in the drug
discovery process and permits dramatically productivity increases.

Company: CEM Corporation
Booth/Stand: 206
Media Contact: Michelle Horn, [e-mail]
Phone:  [phone]
E-mail: [e-mail]
Web: www.cem.com

Product description: CEM offers the most complete line of modular
microwave synthesis systems for discovery, lead optimization, scale
up, low-temperature synthesis, in situ spectroscopic analysis,
high-throughput, and peptide synthesis. Perform pressurized and
atmospheric reactions on all systems and see faster reaction times,
cleaner chemistries, and significantly higher yields than with
conventional methods.

Company description: CEM Corporation, a private company based in
Matthews, North Carolina, is the world's leading provider of
microwave-assisted synthesis systems for the pharmaceutical,
biotechnology, and academic research markets. The Company has
subsidiaries in the United Kingdom, Germany, Italy and France, as well
as a global network of distributors.

Company: Center for Biophysical Sciences & Engineering
Booth/Stand: 616
Media Contact: Sharney Logan
Phone:    [phone]
E-mail:   [e-mail]
Web: www.cbse.uab.edu

Product description: CBSE is a leading structural biology research
center encompassing one of the world's largest x-ray crystallography
units. With over 115 staff, our research focuses on the first steps in
structure based drug design. CBSE is also a NASA research partnership
center focused on bridging access to research in life sciences and
applied engineering that benefits life on earth as well as life in
microgravity environments.

Company description: CBSE is a leading structural biology research
center encompassing one of the world's largest crystallography units.
With over 115 staff our research focuses on the first step in
structure based drug design. CBSE is also a NASA research partnership
center focused on bridging access to research in life sciences and
applied engineering that benefits life on earth as well as life in
microgravity environments.

Company: Chembiotek
Booth/Stand: 503
Media/Investor Relations Contact: Debra Sponholtz, PhD
Phone:    [phone]
E-mail:   [e-mail]
Web: www.chembiotek.com

Company description: Chembiotek Research International is located
in India and supports Pharmaceutical and Biotech companies in
achieving their goals in a cost-effective and efficient manner. At
present, Chembiotek has a capable team of over 120 scientists
specializing in medicinal chemistry, library synthesis, custom
synthesis from mg to kg scale, molecular modeling and biology
including custom assay development and screening.

Company: Metabolon, Inc.
Booth/Stand: 306
Ticker Symbol & Exchange:
Media/Investor Relations Contact: Reid Tripp, VP, Business Development
Phone:  [phone]
E-mail: [e-mail]
Web: www.metabolon.com

Product description: Metabolon's patent-pending technology is
poised to impact drug discovery and development processes by
accurately measuring the spectrum of biochemical changes and mapping
these changes to metabolic pathways. This technology provides data
that is less complex, more precise, more relevant and more
quantitative than genomics, proteomics or transcriptomics.

Company description: Metabolon is an industry leader in the
discovery of biomarkers through the use of metabolomics, a powerful
scientific approach for the discovery and development of drugs and the
early diagnosis of disease states. Metabolon's technology can identify
safer compounds for development, shorten the time for drugs to get to
market and identify novel biomarkers for earlier disease detection.

Company: Molecular Devices Corporation
Booth/Stand: 208
Ticker Symbol & Exchange: MDCC
Media Contact: Cheri Salazar
Investor Relations Contact: Kathleen Vargas
Phone:  [phone]
E-mail: [e-mail]
Web: www.moleculardevices.com

Product description: HT Electrophisiology screening instruments:
Ion channels represent a promising target class that has been
relatively untapped due to the lack of automated high-throughput
instrumentation necessary for supporting screening programs in the
pharmaceutical industry. Molecular Devices electrophysiological
screening instruments, IonWorks Quattro(tm), OpusXpress(r) and
PatchXpress(r) systems, provide a comprehensive solution for ion
channel drug discovery

Company description: Molecular Devices provides innovative
solutions that accelerate and improve drug discovery and life sciences
research. Systems include multimode and dedicated bench-top readers
and liquid handling instruments, systems for electrophysiology,
high-content screening, live-cell imaging, and genomics. The Company
also offers a full line of reagent assay kits and cellular
neuroscience products.

Company:  SIDMAP
Booth/Stand: 502
Media Contact: Fred Siegman
Investor Relations Contact: [e-mail]
Phone:  [phone]
E-mail: [e-mail]
Web:    www.sidmap.com

Product description: SIDMAP provides metabolic profiling services
using its patent-pending, non-radioactive tracer-based technology.
Detailed profiles of tracer incorporation are generated using GC/MS to
determine how the many pathways of the cell's metabolic network are
effected by the presence of a candidate drug or in the disease state
alone. This unique measurement of metabolic flux allows for more
intelligent choices in drug development.

Company description: SIDMAP uses its proprietary metabolome
mapping technology to serve the needs of the pharmaceutical community
in the drug development process by assisting researchers gain a better
understanding of drug effects and human diseases. A SIDMAP profile
provides a detailed understanding of metabolic networks to improve
decision making in target and lead identification, validation and
attrition analysis.

Company: VisualSonics
Booth/Stand: 411
Media Contact: Rob Sandler
Investor Relations Contact: Steve Chackowicz
Phone:  [phone]
E-mail: [e-mail]
Web: www.visualsonics.com

Product description: VisualSonics is the leading developer of
high-resolution in vivo micro-imaging systems devised specifically for
non-invasive small animal research. The Vevo 770(TM) imaging system
enables real-time in vivo visualization and measurement of anatomical
structures and hemodynamic functional in longitudinal studies of mice
and rats with resolution down to 30 microns. The system is designed
for preclinical research and drug discovery applications including

Company: World Life Science Week
Booth/Stand: 521
Media/Investor Relations Contact: Tina El Hage
Phone:  [phone]
E-mail: [e-mail]
Web: www.worldlifescienceweek.com

Product description: With still more than 5 months to go, policy
makers, industry experts, lead scientists, investors and regulators
from over 30 countries have signed up for what is being billed as
Europe's premier life science event of the year - World Life Science
Week. The attraction is the opportunity to participate in an effective
forum aimed to strengthen and develop partnering deals alongside an
outstanding conference and international exhibition.

Company description: This unique event is a joint venture by Reed
Elsevier and Technology Vision Group LLC beginning with Bio Partnering
Europe (Oct 9-11) and continuing with CORDIA Biotechnology Convention
(Oct 11-13). Both groups are highly supportive of the Pharmaceutical
and Biotechnology sector and hope this convergence will stimulate
further growth of the industry in Europe.